Stay updated on Nivolumab +/- Ipilimumab in NECs Clinical Trial
Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.

Latest updates to the Nivolumab +/- Ipilimumab in NECs Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.4 was added, replacing v3.5.3. This signals a small update to the page metadata rather than a substantive content change.SummaryDifference0.1%

- Check8 days agoChange DetectedThe reference to the NIPINEC publication has been updated to show the final JCO article details (April 20, 2026; 44(12):1120-1129) with the DOI, replacing the previous online-ahead-of-print citation.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision: v3.5.3 replaces v3.5.2, indicating a minor release/version update on the page. This change is metadata and does not affect user-facing content.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page’s revision label has been updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.5.0 implemented, replacing the previous v3.4.3.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded a Publications entry citing the J Clin Oncol article for NIPINEC and noted that publications are automatically filled from PubMed. Revision history updated to v3.4.3.SummaryDifference0.3%

Stay in the know with updates to Nivolumab +/- Ipilimumab in NECs Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.